用于治疗距骨血管坏死的全距骨置换术的初步安全性。

Foot & ankle international Pub Date : 2024-11-01 Epub Date: 2024-10-27 DOI:10.1177/10711007241278947
Bijan Abar, Michael S Kim, Samuel B Adams, William R Adams, Annunziato Amendola, Mark E Easley, John Kent Ellington, Samuel E Ford, Andrew E Hanselman, Peter Highlander, John Y Kwon, Christopher P Miller, James A Nunley, Claire Parker, Selene G Parekh, Karl M Schweitzer, Scott B Shawen, Tara Mann, Cambre Kelly
{"title":"用于治疗距骨血管坏死的全距骨置换术的初步安全性。","authors":"Bijan Abar, Michael S Kim, Samuel B Adams, William R Adams, Annunziato Amendola, Mark E Easley, John Kent Ellington, Samuel E Ford, Andrew E Hanselman, Peter Highlander, John Y Kwon, Christopher P Miller, James A Nunley, Claire Parker, Selene G Parekh, Karl M Schweitzer, Scott B Shawen, Tara Mann, Cambre Kelly","doi":"10.1177/10711007241278947","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Total talus replacement (TTR) implants are designed to replace the diseased talar anatomy, reduce pain, maintain ankle range of motion, and restore ankle function after conservative treatments have failed. Currently TTR implants are produced by 3D printing a patient-specific implant designed from the patient's preoperative anatomy. TTR surgery using patient-specific implants is a relatively new technique that remains understudied in the literature. Therefore, the purpose of this investigation was to determine the early safety and potential benefit of the TTR implant in patients with talar avascular necrosis.</p><p><strong>Methods: </strong>This retrospective, multicenter, cohort study evaluates the safety and potential benefits of TTR using 3D-printed patient-specific implants across 4 US centers. The primary outcome was the occurrence of early adverse events after TTR surgery. Secondary outcomes including, pain, and physical function were assessed using the pain visual analog scale (VAS), and Patient-Reported Outcomes Measurement Information System (PROMIS) physical function (PF), respectively.</p><p><strong>Results: </strong>The study team analyzed 15 patients with more than 1 year of follow-up. The mean duration of follow-up was 25.9 months (range: 18.3-41 months). Although 33.3% (5 of 15) of patients experienced adverse events, primarily occurring within the initial 6 months postoperatively, 93% (14 of 15) of patients reported implant survivorship. Of the 5 cases (33.3%) resulting in an adverse event, 3 (60.0%) were determined to be unrelated to the subject device, 2 (40.0%) were determined to be possibly procedure-related, and none (0%) were determined to be device-related.</p><p><strong>Conclusion: </strong>Although further studies are needed to compare TTR with the standard of care, the results of this study demonstrate the relative early safety of TTR surgery using a 3D-printed implant for the treatment of challenging talar pathologies. A larger and longer clinical study is required to see if the efficacy of this approach will be statistically and clinically meaningful.</p>","PeriodicalId":94011,"journal":{"name":"Foot & ankle international","volume":" ","pages":"1258-1265"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Initial Safety of Total Talus Replacement Used to Treat Talar Avascular Necrosis.\",\"authors\":\"Bijan Abar, Michael S Kim, Samuel B Adams, William R Adams, Annunziato Amendola, Mark E Easley, John Kent Ellington, Samuel E Ford, Andrew E Hanselman, Peter Highlander, John Y Kwon, Christopher P Miller, James A Nunley, Claire Parker, Selene G Parekh, Karl M Schweitzer, Scott B Shawen, Tara Mann, Cambre Kelly\",\"doi\":\"10.1177/10711007241278947\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Total talus replacement (TTR) implants are designed to replace the diseased talar anatomy, reduce pain, maintain ankle range of motion, and restore ankle function after conservative treatments have failed. Currently TTR implants are produced by 3D printing a patient-specific implant designed from the patient's preoperative anatomy. TTR surgery using patient-specific implants is a relatively new technique that remains understudied in the literature. Therefore, the purpose of this investigation was to determine the early safety and potential benefit of the TTR implant in patients with talar avascular necrosis.</p><p><strong>Methods: </strong>This retrospective, multicenter, cohort study evaluates the safety and potential benefits of TTR using 3D-printed patient-specific implants across 4 US centers. The primary outcome was the occurrence of early adverse events after TTR surgery. Secondary outcomes including, pain, and physical function were assessed using the pain visual analog scale (VAS), and Patient-Reported Outcomes Measurement Information System (PROMIS) physical function (PF), respectively.</p><p><strong>Results: </strong>The study team analyzed 15 patients with more than 1 year of follow-up. The mean duration of follow-up was 25.9 months (range: 18.3-41 months). Although 33.3% (5 of 15) of patients experienced adverse events, primarily occurring within the initial 6 months postoperatively, 93% (14 of 15) of patients reported implant survivorship. Of the 5 cases (33.3%) resulting in an adverse event, 3 (60.0%) were determined to be unrelated to the subject device, 2 (40.0%) were determined to be possibly procedure-related, and none (0%) were determined to be device-related.</p><p><strong>Conclusion: </strong>Although further studies are needed to compare TTR with the standard of care, the results of this study demonstrate the relative early safety of TTR surgery using a 3D-printed implant for the treatment of challenging talar pathologies. A larger and longer clinical study is required to see if the efficacy of this approach will be statistically and clinically meaningful.</p>\",\"PeriodicalId\":94011,\"journal\":{\"name\":\"Foot & ankle international\",\"volume\":\" \",\"pages\":\"1258-1265\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Foot & ankle international\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/10711007241278947\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/10/27 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Foot & ankle international","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/10711007241278947","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/27 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:全距骨置换(TTR)植入物旨在替代病变的距骨解剖结构,减轻疼痛,保持踝关节活动范围,并在保守治疗失败后恢复踝关节功能。目前,TTR 植入体是通过 3D 打印根据患者术前解剖结构设计的患者特异性植入体来生产的。使用患者特异性植入物进行 TTR 手术是一项相对较新的技术,但文献中的研究仍然不足。因此,本研究旨在确定 TTR 植入物在距骨血管性坏死患者中的早期安全性和潜在益处:这项回顾性、多中心、队列研究评估了美国 4 个中心使用 3D 打印患者特异性植入物进行 TTR 治疗的安全性和潜在益处。主要结果是TTR手术后早期不良事件的发生率。次要结果包括疼痛和身体功能,分别使用疼痛视觉模拟量表(VAS)和患者报告结果测量信息系统(PROMIS)身体功能(PF)进行评估:研究小组对随访时间超过 1 年的 15 名患者进行了分析。平均随访时间为 25.9 个月(范围:18.3-41 个月)。虽然 33.3% 的患者(15 例中的 5 例)出现了不良事件,主要发生在术后最初的 6 个月内,但 93% 的患者(15 例中的 14 例)报告种植体存活。在 5 例(33.3%)导致不良事件的病例中,3 例(60.0%)被确定为与受试器械无关,2 例(40.0%)被确定为可能与手术有关,没有一例(0%)被确定为与器械有关:尽管还需要进一步的研究来比较TTR与标准治疗方法,但本研究结果表明,使用3D打印植入物进行TTR手术治疗具有挑战性的距骨病变是相对安全的。需要进行更大规模和更长时间的临床研究,以确定这种方法的疗效是否具有统计学和临床意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Initial Safety of Total Talus Replacement Used to Treat Talar Avascular Necrosis.

Background: Total talus replacement (TTR) implants are designed to replace the diseased talar anatomy, reduce pain, maintain ankle range of motion, and restore ankle function after conservative treatments have failed. Currently TTR implants are produced by 3D printing a patient-specific implant designed from the patient's preoperative anatomy. TTR surgery using patient-specific implants is a relatively new technique that remains understudied in the literature. Therefore, the purpose of this investigation was to determine the early safety and potential benefit of the TTR implant in patients with talar avascular necrosis.

Methods: This retrospective, multicenter, cohort study evaluates the safety and potential benefits of TTR using 3D-printed patient-specific implants across 4 US centers. The primary outcome was the occurrence of early adverse events after TTR surgery. Secondary outcomes including, pain, and physical function were assessed using the pain visual analog scale (VAS), and Patient-Reported Outcomes Measurement Information System (PROMIS) physical function (PF), respectively.

Results: The study team analyzed 15 patients with more than 1 year of follow-up. The mean duration of follow-up was 25.9 months (range: 18.3-41 months). Although 33.3% (5 of 15) of patients experienced adverse events, primarily occurring within the initial 6 months postoperatively, 93% (14 of 15) of patients reported implant survivorship. Of the 5 cases (33.3%) resulting in an adverse event, 3 (60.0%) were determined to be unrelated to the subject device, 2 (40.0%) were determined to be possibly procedure-related, and none (0%) were determined to be device-related.

Conclusion: Although further studies are needed to compare TTR with the standard of care, the results of this study demonstrate the relative early safety of TTR surgery using a 3D-printed implant for the treatment of challenging talar pathologies. A larger and longer clinical study is required to see if the efficacy of this approach will be statistically and clinically meaningful.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Association of Factors Related to the Size and Hepple Classification of Medial Osteochondral Lesions of the Talus. Utility of 3D Wound Assessment in Monitoring Granulation Tissue Velocity Following Negative-Pressure Wound Therapy in Diabetic Foot Ulcers. The Shape of Things to Come. Talar Morphology of Charcot-Marie-Tooth Patients With Cavovarus Feet. In Vivo Kinematics of the Distal Tibiofibular Syndesmosis With Different Loading Weights.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1